The first wave: HCV NS3 protease inhibitors telaprevir and boceprevir

Title
The first wave: HCV NS3 protease inhibitors telaprevir and boceprevir
Authors
Keywords
-
Journal
ANTIVIRAL THERAPY
Volume 17, Issue 6 Pt B, Pages 1119-1131
Publisher
International Medical Press
Online
2012-12-11
DOI
10.3851/imp2424

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started